Cannabis regulator Kay Doyle jumps to pharma

Greenwich Biosciences manufactures the first FDA-approved cannabis drug

CANNABIS CONTROL COMMISSIONER Kay Doyle is leaving the state oversight panel to take a job as US director of public policy for Greenwich Biosciences, the first company to manufacture an FDA-approved cannabis drug. “It returns me back to really focusing on patients, which is where my heart is,” Doyle said. The five-member Cannabis Control Commission(...)

Read More »